BOPO - BioPower Operations Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue13.42--
Cost of Revenue---
Gross Profit13.42--
Operating Expenses
Research Development---
Selling General and Administrative1,968.8112,021.0031,301.598
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,955.391-2,021.003-1,301.598
Income from Continuing Operations
Total Other Income/Expenses Net-14.53934.267-8.237
Earnings Before Interest and Taxes-1,969.93-1,986.736-1,309.835
Interest Expense241.43106.28532.893
Income Before Tax-2,211.36-2,093.021-1,342.728
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-2,211.36-2,093.021-1,342.728
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,211.36-2,093.021-1,342.728
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,211.36-2,093.021-1,342.728